← Back to Analyst Consensus 
RVPH Buy
REVIVA PHARMACEUTICALS HOLDINGS, INC.
Current Price —
Implied Upside —
Analysts 11
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 16, 2026 (21 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Apr 8, 2026 | Maxim Group | downgrade | Buy → Hold | — | 42% |
| Mar 31, 2026 | Roth Capital | maintain | Buy → Buy | — | 53% |
| Mar 30, 2026 | Alliance Global Partners | maintain | Buy → Buy | — | 41% |
| Mar 5, 2026 | D. Boral Capital | downgrade | Buy → Hold | — | 34% |
| Jan 5, 2026 | Chardan Capital | maintain | Buy → Buy | $2 | 47% |
| Dec 23, 2025 | D. Boral Capital | maintain | Buy → Buy | $2 | 34% |
| Dec 23, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $4 | 44% |
| Nov 19, 2025 | D. Boral Capital | maintain | Buy → Buy | $2 | 34% |
| Oct 28, 2025 | D. Boral Capital | maintain | Buy → Buy | $2 | 34% |
| Oct 27, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $4 | 44% |
| Sep 29, 2025 | Chardan Capital | initiate | — → Buy | $2 | 47% |
| Sep 19, 2025 | D. Boral Capital | maintain | Buy → Buy | $2 | 34% |
| Sep 15, 2025 | Benchmark | maintain | Speculative Buy → Speculative Buy | $7 | 54% |
| Aug 18, 2025 | Roth Capital | reiterate | Buy → Buy | $3 | 53% |
| Aug 18, 2025 | D. Boral Capital | maintain | Buy → Buy | $3 | 34% |
| Aug 15, 2025 | Maxim Group | maintain | Buy → Buy | $2 | 42% |
| Jun 27, 2025 | D. Boral Capital | maintain | Buy → Buy | $3 | 34% |
| Jun 3, 2025 | D. Boral Capital | maintain | Buy → Buy | $3 | 34% |
| May 20, 2025 | D. Boral Capital | maintain | Buy → Buy | $3 | 34% |
| Apr 24, 2025 | D. Boral Capital | maintain | Buy → Buy | $8 | 34% |
| Apr 1, 2025 | D. Boral Capital | maintain | Buy → Buy | $8 | 34% |
| Jan 22, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $11 | 44% |
| Jan 21, 2025 | D. Boral Capital | maintain | Buy → Buy | $15 | 34% |
| Jan 10, 2025 | Maxim Group | upgrade | Hold → Buy | $7 | 42% |
| Jan 10, 2025 | Roth MKM | initiate | — → Buy | $7 | 52% |
| Nov 14, 2024 | D. Boral Capital | maintain | Buy → Buy | $15 | 34% |
| Nov 13, 2024 | D. Boral Capital | maintain | Buy → Buy | $15 | 34% |
| Sep 23, 2024 | EF Hutton | initiate | — → Buy | $15 | 30% |
| Aug 26, 2024 | Benchmark | reiterate | Speculative Buy → Speculative Buy | $17 | 54% |
| Aug 16, 2024 | Maxim Group | downgrade | Buy → Hold | $0 | 42% |
| Jul 11, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $14 | 44% |
| Jun 20, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $14 | 44% |
| Jun 11, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $14 | 44% |
| May 28, 2024 | Benchmark | reiterate | Speculative Buy → Speculative Buy | $17 | 54% |
| Apr 22, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
| Apr 16, 2024 | Benchmark | reiterate | Speculative Buy → Speculative Buy | $17 | 54% |
| Mar 25, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
| Feb 20, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
| Dec 26, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
| Oct 31, 2023 | HC Wainwright & Co. | maintain | Buy → Buy | $20 | 44% |
| Oct 30, 2023 | Roth MKM | reiterate | Buy → Buy | $12 | 52% |
| Sep 20, 2023 | Roth MKM | initiate | — → Buy | $12 | 52% |
| Aug 16, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Jun 26, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Jun 8, 2023 | Benchmark | initiate | — → Speculative Buy | $17 | 54% |
| May 8, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $10 | 44% |
| May 3, 2023 | Maxim Group | maintain | — → Buy | $18 | 42% |
| Apr 4, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $20 | 44% |
| Jan 25, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $10 | 44% |
| Nov 1, 2022 | Maxim Group | maintain | — → Buy | $10 | 42% |
Price Target Trend
Mar 30, 2026 Oct 26, 2026
EPS Estimates
+1y —
0y —
+1q —
0q —
Cross-Platform Signals
No cross-platform signals in the last 90 days